Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
Table 1
Patient characteristics before treatment.
Variables
Control group (n = 50)
O3-AHT group (n = 53)
valuea
Age (yr)
49.08 ± 8.35
48.15 ± 10.92
0.46
Gender
Female
31 (62.0)
29 (54.7)
0.63
Male
19 (38.0)
24 (45.3)
Marital status
Single/divorced
4 (8.0)
5 (9.4)
0.80
Married/co-habiting
46 (92.0)
48 (90.6)
Occupation
Full time
18 (36.0)
24 (45.3)
0.18
Part time
8 (16.0)
11 (20.8)
Sick leave
3 (6.0)
2 (3.7)
Retired
21 (42.0)
16 (30.2)
Height (cm)
165.52 ± 11.74
164.38 ± 13.28
0.64
Weight (kg)
63.26 ± 13.96
64.99 ± 12.59
0.51
BMI
19.70 ± 3.08
19.68 ± 2.80
0.87
Insomnia duration (mth)
19.18 ± 9.78
21.36 ± 7.78
0.22
Insomnia severity (ISI)
20.58 ± 4.24
21.13 ± 3.08
0.45
Pain duration (mth)
16.44 ± 7.84
17.49 ± 9.51
0.54
Pain severity (VAS)
7.69 ± 1.24
7.35 ± 1.22
0.84
Values are the means ± standard deviation and n (%). at-test or chi-square test as appropriate. O3-AHT, ozonated autohemotherapy; BMI, body mass index; ISI, insomnia severity index; VAS, visual analogue scale.
